Department of Animal Science and Aquaculture, Faculty of Agriculture, Dalhousie University, Truro, Nova Scotia, Canada.
Immun Inflamm Dis. 2020 Jun;8(2):150-164. doi: 10.1002/iid3.290. Epub 2020 Mar 13.
Aleutian mink disease virus (AMDV) causes a serious health problem for mink globally. The disease has no cure nor an effective vaccine and selection for tolerance using antibody titer is adopted by many mink farmers. The objective of this study was to investigate the effects of various doses of a local AMDV isolate on the response of black American mink to infection with AMDV.
Eight black American mink were each inoculated intranasally with 0.5 mL of eight serial 10-fold dilutions (10 to 10 ) of a 10% spleen homogenate containing a local AMDV isolate. Blood samples were collected on days 0, 20, 35, 56, 84, 140, and 196 postinoculation (dpi). Anti-AMDV antibodies and viral DNA were tested by counter-immunoelectrophoresis (CIEP) and PCR, respectively. Animals that were PCR or CIEP positive at 196 dpi (n = 41) were killed at 218 dpi, and samples of blood and seven organs were tested by CIEP and PCR.
Antibody production persisted in all seroconverted mink until the termination of the experiment, whereas 71.1% of the mink showed short-lived viremia. Significant associations were observed between inoculum dose and the incidence of viremia until 84 dpi which disappeared thereafter, whereas associations between inoculum dose and the incidence of seropositive mink were significant on all sampling occasions. Antibody titer at 218 dpi significantly decreased with decreasing inoculum dose. AMDV DNA was detected in the bone marrow, lymph nodes, and spleen samples of almost all mink inoculated at every dose but was not detected in other organs of some mink.
CIEP is more accurate than PCR for detecting AMDV infection in mink. Using antibody titer in naturally infected mink may not be accurate for the identification of tolerant mink.
阿留申病病毒(AMDV)对全球水貂的健康造成严重威胁。该疾病目前尚无治疗方法,也没有有效的疫苗,因此许多水貂养殖户选择通过抗体滴度进行耐病性选择。本研究旨在调查当地 AMDV 分离株的不同剂量对感染 AMDV 的黑色美洲水貂的反应的影响。
8 只黑色美洲水貂分别用 0.5ml 含当地 AMDV 分离株的 10%脾匀浆进行 8 个 10 倍连续稀释(10 到 10 )的鼻腔接种。在接种后 0、20、35、56、84、140 和 196 天采集血样。通过对流免疫电泳(CIEP)和 PCR 分别检测抗 AMDV 抗体和病毒 DNA。在 196 天时通过 PCR 或 CIEP 呈阳性的动物(n=41)在 218 天被处死,通过 CIEP 和 PCR 检测血液和七个器官的样本。
所有血清转换的水貂均持续产生抗体,直至实验结束,而 71.1%的水貂出现短暂的病毒血症。在接种后 84 天之前,观察到接种剂量与病毒血症发生率之间存在显著相关性,此后这种相关性消失,而在所有采样时间点,接种剂量与血清阳性水貂的发生率之间均存在显著相关性。218 天时的抗体滴度随着接种剂量的降低而显著降低。骨髓、淋巴结和脾脏样本中几乎所有接种了各种剂量的水貂都检测到 AMDV DNA,但在一些水貂的其他器官中未检测到。
CIEP 比 PCR 更准确地检测水貂中的 AMDV 感染。在自然感染的水貂中使用抗体滴度可能无法准确识别耐病水貂。